(Q41509280)

1 October 2017

1 reference

title

Reversal of parkinsonian symptoms in primates by antagonism of excitatory amino acid transmission: potential mechanisms of action (English)

1 reference

1 October 2017

1 reference

Mitchell IJ

1

1 reference

1 October 2017

Carroll CB

series ordinal

2

1 reference

1 October 2017

publication date

1 July 1997

1 reference

Neuroscience & Biobehavioral Reviews

1 October 2017

published in

1 reference

1 October 2017

volume

21

1 reference

1 October 2017

issue

4

1 reference

1 October 2017

page(s)

469-475

1 reference

The functional anatomy of basal ganglia disorders

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Cellular localisation of enkephalin gene expression in MPTP-treated cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Neurochemical and behavioural investigations of the NMDA receptor-associated glycine site in the rat striatum: functional implications for treatment of parkinsonian symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Excitatory amino acid receptors and synaptic plasticity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Effect of the NMDA antagonist MK-801 on MPTP-induced parkinsonism in the monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Interactions between the glutamate and glycine recognition sites of the N-methyl-D-aspartate receptor from rat brain, as revealed from radioligand binding studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Polyamines modulate [3H]L-689,560 binding to the glycine site of the NMDA receptor from rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Excitatory amino acids in the developing brain: ontogeny, plasticity, and excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

The AMPA receptor antagonist NBQX has antiparkinsonian effects in monoamine-depleted rats and MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Glycine site antagonists abolish dopamine D2 but not D1 receptor mediated catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Molecular diversity of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

The AMPA receptor antagonist NBQX does not alter the motor response induced by selective dopamine agonists in MPTP-treated monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Anatomic correlation of NMDA and 3H-TCP-labeled receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Volatile anesthetics and NMDA receptors. Enflurane inhibition of glutamate-stimulated [3H]MK-801 binding and reversal by glycine.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Differential stimulation of [3H]MK-801 binding to subpopulations of NMDA receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Molecular cloning and characterization of the rat NMDA receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

NBQX does not affect learning and memory tasks in mice: a comparison with D-CPPene and ifenprodil

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Differential regulation of striatal preproenkephalin mRNA by D1 and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Agonist-like character of the (R)-enantiomer of 1-hydroxy-3-amino-pyrrolid-2-one (HA-966)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Modulation of NMDA receptor responsiveness by neurotransmitters, drugs and chemical modification

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Allosteric modulation of N-methyl-D-aspartate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

The NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Structures and properties of seven isoforms of the NMDA receptor generated by alternative splicing

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Mechanism Underlying Protective Effect of MK-801 against NMDA-Induced Neuronal Injury in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Developmental switch in the expression of NMDA receptors occurs in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

The competitive NMDA antagonist CGP40.116 enhances L-dopa response in MPTP-treated marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Cloning, expression and modulation of a mouse NMDA receptor subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

Quisqualate- and NMDA-sensitive [3H]glutamate binding in primate brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2896%2900036-X

7 January 2021

10.1016/S0149-7634(96)00036-X

Identifiers

DOI

1 reference

1 October 2017

1 reference